Phase II study of combined immunotherapy, chemotherapy, and radiotherapy in the postoperative treatment of advanced non-small-cell lung cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/10687149

Download in:

View as

General Info

PMID
10687149